111 related articles for article (PubMed ID: 38007771)
21. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
22. Testing lncRNAs signature as clinical stage-related prognostic markers in gastric cancer progression using TCGA database.
Beeraka NM; Gu H; Xue N; Liu Y; Yu H; Liu J; Chen K; Nikolenko VN; Fan R
Exp Biol Med (Maywood); 2022 Apr; 247(8):658-671. PubMed ID: 35068210
[TBL] [Abstract][Full Text] [Related]
23. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
Chen F; Wang Y; Zhang X; Fang J
Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
[TBL] [Abstract][Full Text] [Related]
24. Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer.
Xue S; Ma M; Bei S; Li F; Wu C; Li H; Hu Y; Zhang X; Qian Y; Qin Z; Jiang J; Feng L
Front Immunol; 2021; 12():702615. PubMed ID: 34322132
[TBL] [Abstract][Full Text] [Related]
25. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.
Yu T; Jia W; An Q; Cao X; Xiao G
Med Sci Monit; 2018 Mar; 24():1847-1855. PubMed ID: 29596399
[TBL] [Abstract][Full Text] [Related]
26. Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer.
Qi M; Yu B; Yu H; Li F
Cancer Med; 2020 Mar; 9(5):1798-1817. PubMed ID: 31923354
[TBL] [Abstract][Full Text] [Related]
27. Microarray profile analysis identifies ETS1 as potential biomarker regulated by miR-23b and modulates TCF4 in gastric cancer.
Mei D; Qi Y; Xia Y; Ma J; Hu H; Ai J; Chen L; Wu N; Liao D
World J Surg Oncol; 2021 Oct; 19(1):311. PubMed ID: 34686186
[TBL] [Abstract][Full Text] [Related]
28. Analysis of expression differences of immune genes in non-small cell lung cancer based on TCGA and ImmPort data sets and the application of a prognostic model.
Sun L; Zhang Z; Yao Y; Li WY; Gu J
Ann Transl Med; 2020 Apr; 8(8):550. PubMed ID: 32411773
[TBL] [Abstract][Full Text] [Related]
29. Construction of a three-component regulatory network of transcribed ultraconserved regions for the identification of prognostic biomarkers in gastric cancer.
Khalafiyan A; Emadi-Baygi M; Wolfien M; Salehzadeh-Yazdi A; Nikpour P
J Cell Biochem; 2023 Mar; 124(3):396-408. PubMed ID: 36748954
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
Front Oncol; 2022; 12():878546. PubMed ID: 35712475
[TBL] [Abstract][Full Text] [Related]
31. KRT15, INHBA, MATN3, and AGT are aberrantly methylated and differentially expressed in gastric cancer and associated with prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Dai DQ
Pathol Res Pract; 2019 May; 215(5):893-899. PubMed ID: 30718100
[TBL] [Abstract][Full Text] [Related]
32. A nine-gene signature as prognostic biomarker in gastric cancer by bioinformatics analysis.
Wang G; Ren Z; Zhao Y; Li Y
Clin Transl Oncol; 2023 Nov; 25(11):3296-3306. PubMed ID: 37041435
[TBL] [Abstract][Full Text] [Related]
33. A DNA methylation signature to improve survival prediction of gastric cancer.
Peng Y; Wu Q; Wang L; Wang H; Yin F
Clin Epigenetics; 2020 Jan; 12(1):15. PubMed ID: 31959204
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
35. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
[TBL] [Abstract][Full Text] [Related]
36. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
37. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
38. TCGA dataset‑based construction and integrated analysis of aberrantly expressed long non‑coding RNA mediated competing endogenous RNA network in gastric cancer.
He W; Zhang D; Li X; Wu J; Yang X; Wang Q; Lu W; Jiang J; Wu C
Oncol Rep; 2018 Dec; 40(6):3511-3522. PubMed ID: 30272352
[TBL] [Abstract][Full Text] [Related]
39. Identification of Hub Genes Associated With the Development of Stomach Adenocarcinoma by Integrated Bioinformatics Analysis.
Zhang K; Wang J; Zhu Y; Liu X; Li J; Shi Z; Cao M; Li Y
Front Oncol; 2022; 12():844990. PubMed ID: 35686089
[TBL] [Abstract][Full Text] [Related]
40. Construction and Comprehensive Analysis for Dysregulated Long Non-Coding RNA (lncRNA)-Associated Competing Endogenous RNA (ceRNA) Network in Gastric Cancer.
Li F; Huang C; Li Q; Wu X
Med Sci Monit; 2018 Jan; 24():37-49. PubMed ID: 29295970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
